Subscribe to RSS

DOI: 10.1055/s-0045-1802968
Characteristics of Tinnitus in Patients Affected by COVID-19: A Systematic Review
Authors
Funding The authors declare that they did not receive funding from agencies in the public, private, or non-profit sectors to conduct the present study.

Abstract
Introduction
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has brought up reports of an increase in new cases of tinnitus and changes in chronic and/or preexisting episodes. Nevertheless, there is no established data on the characteristics of tinnitus and its correlation with coronavirus disease 2019 (COVID-19).
Objective
To analyze the characteristics of tinnitus in subjects affected by COVID-19 while detailing the correlation between these two factors.
Data Synthesis
We found 327 articles, 37 of which were selected: 11 cross-sectional studies, 4 case-control studies, 3 cohort studies, and 19 observational studies. The sum of the samples totaled 399,524 patients included in the present review. The prevalence of new tinnitus varied from 0.2% to 96.2%. Most articles provided incomplete information or were missing information. Systemic arterial hypertension was the most common underlying disease. Finally, we found a predominance of hearing loss and olfactory and taste disorders, followed by fever and cough.
Conclusion
The prevalence of new tinnitus ranged from 0.2 to 96.2%, whereas the prevalence of preexisting tinnitus varied from 8 to 76.2%. It was not possible to satisfactorily assess the characteristics of tinnitus. Therefore, a direct correlation between tinnitus and COVID-19 could not be determined, as this symptom may be influenced by other factors.
Publication History
Received: 14 February 2024
Accepted: 01 January 2025
Article published online:
20 August 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Daniella Wuttke Doutrelepont, Carolina Pereira Fernandes, Luiza Silva Vernier, Marcia Salgado Machado. Characteristics of Tinnitus in Patients Affected by COVID-19: A Systematic Review. Int Arch Otorhinolaryngol 2025; 29: s00451802968.
DOI: 10.1055/s-0045-1802968
-
References
- 1 Nada EH, El-Gharib AM, Mandour M. Common and uncommon audio-vestibular findings in COVID-19 patients. Egypt J Otolaryngol 2022; 38 (01) 119
- 2 Çıldir B. An age-related investigation of audio-vestibular symptoms in individuals with Covid-19 positive. Cukurova Medical Journal 2021; 46 (04) 1537-1547
- 3 Gallus R, Melis A, Rizzo D. et al. Audiovestibular symptoms and sequelae in COVID-19 patients. J Vestib Res 2021; 31 (05) 381-387 . Available from: https://content.iospress.com/download/journal-of-vestibular-research/ves201505?id=journal-of-vestibular-research%2Fves201505
- 4 Beukes EW, Baguley DM, Jacquemin L. et al. Changes in Tinnitus Experiences During the COVID-19 Pandemic. Front Public Health 2020; 8: 592878
- 5 Saraf A, Manhas M, Kalsotra P, Ahmad R. COVID-19 and tinnitus—a tertiary care Centre experience. Egypt J Otolaryngol 2022; 38 (01) 66
- 6 Yaseen NK, Al-Ani RM, Ali Rashid R. COVID-19-related sudden sensorineural hearing loss. Qatar Med J 2021; 2021 (03) 58 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555677/ cited 2022Apr19 [Internet]
- 7 Gosavi S, Nagarajan S, Shah NJ, Thomas NAT, Kumar KR, Sangole V. ENT Symptomology in Active COVID-19 Patients in our Tertiary Care Centre. Indian J Otolaryngol Head Neck Surg 2022; 74 (2, Suppl 2) 3092-3097
- 8 Ali ST, Kang AK, Patel TR. et al. Evolution of neurologic symptoms in non-hospitalized COVID-19 “long haulers”. Ann Clin Transl Neurol 2022; 9 (07) 950-961
- 9 Zięba N, Lisowska G, Dadok A, Kaczmarek J, Stryjewska-Makuch G, Misiołek M. Frequency and Severity of Ear-Nose-Throat (ENT) Symptoms during COVID-19 Infection. Medicina (Kaunas) 2022; 58 (05) 623
- 10 Espinoza-Valdez A, Celis-Aguilar E, Torres-Gerardo F, Cantú-Cavazos N, Dehesa-Lopez E. In Search of a Neurotologic Profile in COVID-19 - A Study in Health Care Workers. Cureus 2022; 14 (01) e21015
- 11 Thrane JF, Britze A, Fjaeldstad AW. Incidence and duration of self-reported hearing loss and tinnitus in a cohort of COVID-19 patients with sudden chemosensory loss: A STROBE observational study. Eur Ann Otorhinolaryngol Head Neck Dis 2022; 139 (03) 125-128
- 12 AlJasser A, Alkeridy W, Munro KJ, Plack CJ. Is COVID-19 associated with self-reported audio-vestibular symptoms?. Int J Audiol 2022; 61 (10) 832-840
- 13 Erinc M, Mutlu A, Celik S, Kalcioglu MT, Szczepek AJ. Long-Term Effects of COVID-19 and the Pandemic on Tinnitus Patients. Front Neurol 2022; 13: 921173
- 14 Deva FAL, Gupta A, Manhas M, Kalsotra P. Neuro-otological Symptoms: An Atypical Aspect of COVID-19 Disease. Indian J Otolaryngol Head Neck Surg 2022; 74 (Suppl. 02) 3273-3282
- 15 Liang Y, Xu J, Chu M. et al. Neurosensory dysfunction: A diagnostic marker of early COVID-19. Int J Infect Dis 2020; 98: 347-352
- 16 Özçelik Korkmaz M, Eğilmez OK, Özçelik MA, Güven M. Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection. Eur Arch Otorhinolaryngol 2021; 278 (05) 1675-1685
- 17 Elibol E. Otolaryngological symptoms in COVID-19. Eur Arch Otorhinolaryngol 2021; 278 (04) 1233-1236
- 18 Degen CV, Mikuteit M, Niewolik J. et al. Self-reported Tinnitus and Vertigo or Dizziness in a Cohort of Adult Long COVID Patients. Front Neurol 2022; 13: 884002
- 19 Almishaal AA, Alrushaidan AA. Short- and Long-Term Self-Reported Audiovestibular Symptoms of SARS-CoV-2 Infection in Hospitalized and Nonhospitalized Patients. Audiol Neurootol 2022; 27 (04) 297-311
- 20 Bhatta S, Sharma S, Sharma D. et al. Study of Hearing Status in COVID-19 Patients: A Multicentered Review. Indian J Otolaryngol Head Neck Surg 2022; 74 (Suppl. 02) 3036-3042
- 21 Viola P, Ralli M, Pisani D. et al. Tinnitus and equilibrium disorders in COVID-19 patients: preliminary results. Eur Arch Otorhinolaryngol 2020
- 22 Kartal A, Kılıç M. Tinnitus in patients recovering after COVID-19: observational and cross-sectional study. Eur Arch Otorhinolaryngol 2023; 280 (02) 573-580
- 23 Ferreira RJ dos S, Barboza HN, Araújo AL de L e S, Paiva SF de, Rosa MRD da. Auditory and vestibular symptoms after COVID-19 infection: a preliminary Brazilian report. Rev CEFAC 2021; 23 (06) e8121
- 24 Hassani S, Lazem M, Jafari Z. No lasting impact of Covid-19 on the auditory system: a prospective cohort study. J Laryngol Rhinol Otol 2021; 135 (12) 1063-1068
- 25 Verma H, Shah J, Akhilesh K, Shukla B. Patients' perspective about speech, swallowing and hearing status post-SARS-CoV-2 (COVID-19) recovery: E-survey. Eur Arch Otorhinolaryngol 2022; 279 (05) 2523-2532
- 26 Saunders GH, Beukes E, Uus K, Armitage CJ, Kelly J, Munro KJ. Shedding Light on SARS-CoV-2, COVID-19, COVID-19 Vaccination, and Auditory Symptoms: Causality or Spurious Conjunction?. Front Public Health 2022; 10: 837513
- 27 Freni F, Meduri A, Gazia F. et al. Symptomatology in head and neck district in coronavirus disease (COVID-19): A possible neuroinvasive action of SARS-CoV-2. Am J Otolaryngol 2020; 41 (05) 102612
- 28 Figueiredo RR, Penido NO, de Azevedo AA. et al. Tinnitus emerging in the context of a COVID-19 infection seems not to differ in its characteristics from tinnitus unrelated to COVID-19. Front Neurol 2022; 13: 974179
- 29 Wu L, Peng H, He Y, Pu L, Zhong S. An online survey on clinical characteristics of otologic symptoms linked to COVID-19 infection. Front Public Health 2023; 11: 1184262
- 30 Aldè M, Di Berardino F, Ambrosetti U. et al. Audiological and vestibular symptoms following SARS-CoV-2 infection and COVID-19 vaccination in children aged 5-11 years. Am J Otolaryngol 2023; 44 (01) 103669
- 31 Borda Pedraza KA, Moreno Lopez SM, Amaya-Nieto J. et al. Auditory function in symptomatic patients recovered from SARS-CoV-2 and unexposed patients: An analytical cross-sectional study. J Otol 2023; 18 (03) 118-124 ; Epub ahead of print
- 32 Almishaal AA. Comparative Study of Audiovestibular Symptoms between Early and Late Variants of COVID-19. Audiology Res 2022; 12 (06) 680-695
- 33 Kwaśniewska A, Kwaśniewski K, Skorek A, Tretiakow D, Jaźwińska-Curyłło A, Burduk P. Correlation of ENT Symptoms with Age, Sex, and Anti-SARS-CoV-2 Antibody Titer in Plasma. J Clin Med 2023; 12 (02) 610-610
- 34 Africa RE, Westenhaver ZK, Zimmerer RE, McKinnon BJ. Evaluation of Disturbances in Hearing, Tinnitus, and Dizziness as Signs of COVID-19 Infection. Otol Neurotol 2023; 44 (02) 126-133 . Available from: https://pubmed.ncbi.nlm.nih.gov/36537235/
- 35 Bilgin S, Yamanoğlu A, Kayalı A. et al. Long COVID symptoms among outpatients with COVID-19: a descriptive study. Cukurova Med J 2023; 48 (01) 243-252
- 36 Elmazny A, Magdy R, Hussein M. et al. Neuropsychiatric post-acute sequelae of COVID-19: prevalence, severity, and impact of vaccination. Eur Arch Psychiatry Clin Neurosci 2023; 273 (06) 1349-1358
- 37 Dorobisz K, Pazdro-Zastawny K, Misiak P, Kruk-Krzemień A, Zatoński T. Sensorineural Hearing Loss in Patients with Long-COVID-19: Objective and Behavioral Audiometric Findings. Infect Drug Resist 2023; 16: 1931-1939
- 38 Khanna SK, Maheshwari S, Bayad HC, Adersh MK, Rajput NS. The Role of Otorhinolaryngological Manifestations of Mild Covid-19 Disease in Hilly Terrain: Lessons Learnt at a Secondary Care Hospital. Indian J Otolaryngol Head Neck Surg 2022; 74 (Suppl. 02) 3337-3343
- 39 Esteves CC, Brandão FN, Siqueira CGA, Carvalho Sda S. Audição, zumbido e qualidade de vida: um estudo piloto. Rev CEFAC 2012; 14 (05) 836-843
- 40 Home - 2020 - The Centre for Evidence-Based Medicine [Internet]. The Centre for Evidence-Based Medicine. 2020 [cited 2023 Jun 5]. Available from: https://www.cebm.net/
- 41 Atkins D, Best D, Briss PA. et al; GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004; 328 (7454): 1490-1494 http://dx.doi.org/10.1136/bmj.328.7454.1490
- 42 Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151 (04) 264-269 , W64
- 43 El-Anwar MW, Elzayat S, Fouad YA. ENT manifestation in COVID-19 patients. Auris, Nasus, Larynx, v. 47, n. 4, p. 559–564, 1 ago. 2020. https://doi.org/10.1016/j.anl.2020.06.003
- 44 Alves B / O / OM. Zumbido no ouvido | Biblioteca Virtual em Saúde MS [Internet]. [cited 2023 Jul 6]. Available from: https://bvsms.saude.gov.br/zumbido-no-ouvido/#:~:text=A%20impress%C3%A3o%20de% 20que%20o
- 45 Carneiro CS, Silva REPD, Oliveira JRM, Mondelli MFCG. Associação do zumbido e a hipertensão arterial sistêmica autorreferida: estudo retrospectivo. CoDAS 2022; 34 (06) e20210236
- 46 Ribeiro GE, da Silva DPC. Audiological implications of COVID-19: an integrative literature review. Revista CEFAC [Internet]. 2021 [cited 2021 Aug 13];23(1). Available from: https://www.scielo.br/j/rcefac/a/LrN4b rfrsrhfkqc6ZvCYjLh/?lang=en&format = pdf
- 47 Baig AM. Pathways and Pathogenesis of Hearing Deficits, Tinnitus, and Vertigo in COVID-19. ACS Chem Neurosci 2021; 12 (23) 4368-4370
- 48 Gonçalves LF, Patatt FSA, de Paiva KM, Haas P. Ototoxic effects of hydroxychloroquine. Rev Assoc Med Bras 2021; 67 (67, Suppl 1) 108-114
- 49 Little C, Cosetti MK. A Narrative Review of Pharmacologic Treatments for COVID-19: Safety Considerations and Ototoxicity. Laryngoscope 2021; 131 (07) 1626-1632
- 50 Position Statement and Clinical Practice Guidelines Ototoxicity Monitoring [internet]. American Academy of Audiology; 2009. Accessed Jun 12, 2023 at: https://audiology-web.s3.amazonaws.com/migrated/OtoMonGuidelines.pdf_539974c40999c1.58842217.pdf
- 51 Hulley SB, Cummings SR, Browner WS, Grady DG, Newman TB. Outlining clinical research. 4th ed.. Artmed Editora; 2015